1. China Stocks

  2. •

    Retail trade

  3. •

    Drugstore chains
Sipai Health Technology Co., Ltd.

Sipai Health Technology Co., Ltd.

1.35
HKD
+0.06
(+4.26%)
1.87BMarket Cap
Mar 23Next Earn
Sipai Health Technology Co., Ltd.
HKEX:314
(Hong Kong Exchange)

Recent

price

1.35

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
CNY
1.36
3.54
4.55
36.63
7.32
7.14
3.44
- -
Revenue per Share
-0.78
-1.37
-4.9
-12.19
-0.4
-0.51
-0.21
- -
Basic EPS, GAAP
-0.45
-0.27
-0.84
-1.72
-0.22
-0.11
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-1.32
-2.35
-7.12
2.41
2.13
1.6
1.25
1.25
Book Value per Share
-1.44
-2.47
-7.3
2.23
2
1.55
1.22
1.22
Tangible Book Value per Share
763
763
763
112
644
639
602
601
Basic Weighted Avg Shares
1,039
2,700
3,474
4,119
4,712
4,565
2,071
- -
Sales/Revenue/Turnover
-26.8
-14.05
-20.96
-14.88
-5.22
-6.12
-4.46
- -
Operating Margin (%)
30
48
54
49
53
49
27
- -
Depreciation Expense
-595
-1,043
-3,740
-1,371
-256
-324
-124
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-57.23
-38.63
-107.67
-33.27
-5.43
-7.09
-6
- -
Profit Margin (%)
621
1,679
1,657
1,640
1,301
944
572
572
Working Capital
45
37
53
39
39
26
13
13
LT Debt
-1,007
-1,792
-5,431
1,834
1,631
1,202
900
900
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
-14.8
-22.76
-11.49
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
20
14
10
LT Borrowings
- -
- -
- -
LT Finance Leases
26
11
13
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
764
750
749
Market Capitalization
3,913
3,176
1,677

Working Capital

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
1,980
1,539
1,263
Cash, Cash Equivalents & STI
920
598
618
Accounts Receivable, Net
261
215
155
Inventories
194
92
67
Total Current Liabilities
1,037
865
690
Payables & Accruals
- -
- -
- -
ST Debt
20
14
10
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
1.37%
-25.1%
Free Cash Flow
- -
-7.36%
-100.18%
Net Income, GAAP
- -
15.79%
-61.61%
Sales/Revenue/Turnover
- -
0.78%
-54.64%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
4,712
2024
- -
- -
4,565
2025
- -
- -
2,071

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.4
2024
- -
- -
-0.51
2025
- -
- -
-0.21

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -
Similar Companies
CVS Health Corporation (NYSE:CVS)
MatsukiyoCocokara & Co. (TSE:3088)
Guardian Pharmacy Services, Inc. (NYSE:GRDN)
TSURUHA Holdings, Inc. (TSE:3391)
MedPlus Health Services Ltd. (NSE:MEDPLUS)
Raia Drogasil S.A. (B3:RADL3)
Business
Sipai Health Technology Co., Ltd., also recognized as Medbanks Health Technology, functions as a prominent medical technology and health management enterprise within the People's Republic of China. This company delivers its services through three principal divisions: Specialty Pharmacy Operations, Clinical Research Support, and Health Coverage Solutions. The Specialty Pharmacy Operations segment manages specialized pharmacies, offering innovative medications, particularly for oncology and complex conditions, along with expert pharmacist guidance and a comprehensive pharmaceutical supply chain. In 2024, this division began a strategic restructuring to better align with the company's "health insurance plus healthcare management" model, shifting focus away from general medication distribution. The Clinical Research Support division assists pharmaceutical companies and trial institutions with site management organization services, encompassing trial feasibility, participant recruitment, data handling, and comprehensive on-site study support, including specialized medical imaging assessments. The Health Coverage Solutions division delivers insurance brokerage services to insurers and comprehensive health management programs for both insurance providers and corporate clients, including tailored "insurance + health + medical" offerings. Established in 2014, the company maintains its primary operational hubs across China, including Guangzhou, Shanghai, and Beijing.